BioCentury
ARTICLE | Company News

Upsher-Smith, MRC deal

December 8, 2014 8:00 AM UTC

Upsher-Smith’s Proximagen Ltd. U.K. subsidiary and MRC partnered to identify and develop small molecules targeting macrophage migration inhibitory factor (MIF) to treat inflammatory and autoimmune di...